"Diuretics, Osmotic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds that increase urine volume by increasing the amount of osmotically active solute in the urine. Osmotic diuretics also increase the osmolarity of plasma.
Below are MeSH descriptors whose meaning is more general than "Diuretics, Osmotic".
Below are MeSH descriptors whose meaning is more specific than "Diuretics, Osmotic".
This graph shows the total number of publications written about "Diuretics, Osmotic" by people in Harvard Catalyst Profiles by year, and whether "Diuretics, Osmotic" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 1 | 0 | 1 |
| 1999 | 0 | 1 | 1 |
| 2000 | 0 | 1 | 1 |
| 2001 | 1 | 1 | 2 |
| 2002 | 1 | 3 | 4 |
| 2004 | 1 | 1 | 2 |
| 2006 | 1 | 0 | 1 |
| 2011 | 0 | 2 | 2 |
| 2012 | 2 | 1 | 3 |
| 2014 | 0 | 1 | 1 |
| 2016 | 1 | 1 | 2 |
| 2019 | 3 | 1 | 4 |
Below are the most recent publications written about "Diuretics, Osmotic" by people in Profiles.
-
Hyperosmolar Therapy in Pediatric Severe Traumatic Brain Injury-A Systematic Review. Crit Care Med. 2019 12; 47(12):e1022-e1031.
-
Hypertonic Mannitol for the Prevention of Intradialytic Hypotension: A Randomized Controlled Trial. Am J Kidney Dis. 2019 10; 74(4):483-490.
-
Effects of Osmotic Therapy on Pupil Reactivity: Quantification Using Pupillometry in Critically Ill Neurologic Patients. Neurocrit Care. 2019 04; 30(2):307-315.
-
Mannitol decreases neocortical epileptiform activity during early brain development via cotransport of chloride and water. Neurobiol Dis. 2019 05; 125:163-175.
-
High Stroke Volume Variation Method by Mannitol Administration Can Decrease Blood Loss During Donor Hepatectomy. Medicine (Baltimore). 2016 Jan; 95(2):e2328.
-
Introduction: The Past, Present, and Future of AKI Therapeutics. Semin Nephrol. 2016 Jan; 36(1):7.
-
Management of raised intracranial pressure and hyperosmolar therapy. Pract Neurol. 2014 Jun; 14(3):152-8.
-
Continuous hyperosmolar therapy for traumatic brain injury-associated cerebral edema: as good as it gets, or an iatrogenic secondary insult? J Clin Neurosci. 2013 Jan; 20(1):30-1.
-
Hyperosmolar therapy for raised intracranial pressure. N Engl J Med. 2012 Aug 23; 367(8):746-52.
-
Preservation of blood pressure stability with hypertonic mannitol during hemodialysis initiation. Am J Nephrol. 2012; 36(2):168-74.